Registration For The 3rd Alzheimer's-Focused #C4CT Summit Has Closed Due to Overwhelming Interes
Brewer Sports International (BSI), a multi-faceted global sports advisory firm, and Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to cell cycle dysregulation, endoplasmic reticulum stress, neurodegeneration and apoptosis, would like to announce that owing to the popularity of the 3rd Alzheimer’s-focused #C4CT Summit powered by MDM Worldwide, the Coalition for Concussion Treatment is reluctantly unable to accept any new registrants. This summit will be the largest to date with hundreds of confirmed guests including doctors and medical researchers specializing in the treatment of neurodegenerative diseases, international ambassadors, athletes and victims of traumatic brain injury (TBI). The summit will cover Alzheimer’s disease and other neurodegenerative diseases and the emerging link between traumatic brain injury and neurological conditions like these.
The recent announcement of many panelists including Thomas Arendt, Managing Director of the Paul Flechsig Institute of Brain Research, Leipzig University and Director of the Alzheimer Centre Leipzig, The Honorable James Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), Andrew Brandt, NFL analysts for ESPN, Andrea Kremer, Chief Correspondent for Player Health and Safety at the NFL Network, and many current and former professional athletes have contributed to adding great value to the up-coming conference.
Other key speakers are The Honorable Chaka Fattah (D-PA), Dr. Robert Cantu, Dr. Robert Stern, and many more specialists that can be found listed at www.c4ctsummit.com.
A live stream of this event will be available at webtv.un.org.
#C4CT MISSION
The Coalition for Concussion Treatment (#C4CT) serves as a platform to spread awareness about concussions and the severe effects of Traumatic Brain Injury (TBI). Through a global campaign uniting people who are passionate about the cause, #C4CT fosters the critical discussions and partnerships needed to enhance research, treatment efforts and prevention. The overall goal of the coalition is to continue building awareness of key scientific and medical advances in an ongoing effort to identify and develop new TBI treatment opportunities.
#C4CT CONCUSSION AWARENESS SUMMIT
Thursday, July 31, 2014
United Nations, New York City
Door open at 8:30 am // Summit starts at 9:00 am
Presented By: Amarantus BioScience and Brewer Sports International
Powered By: MDM Worldwide
Topics Include: The Current State of Sports Concussions, TBI and the Potential Link to Alzheimer's Disease, Alzheimer's Research and Potential Treatments, Funding and Public Policy, Current and Former Professional Athletes' Personal Stories
More Info on: www.c4ctsummit.com
Share your support for #C4CT on Twitter!
About Amarantus BioScience Holdings, Inc.
Amarantus BioScience Holdings (AMBS) is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. AMBS has licensed Eltoprazine ("Eltoprazine"), a phase 2b ready indication for Parkinson's Levodopa induced dyskinesia and Adult ADHD. AMBS has an exclusive worldwide license to the Lymphocyte Proliferation test ("LymPro Test(R)") for Alzheimer's disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. AMBS also owns intellectual property for the diagnosis of Parkinson's disease ("NuroPro") and the discovery of neurotrophic factors ("PhenoGuard"). Amarantus operations are located at Janssen Labs @QB3 in San Francisco, CA. For further information please visit www.Amarantus.com, or connect with the Company on Facebook, LinkedIn, Twitter and Google+.
About Brewer Sports International
Brewer Sports International (BSI) is a multi-faceted sports advisory firm within The Brewer Group Companies with a focus on the business of sports, wellness and media for professional athletes, sports agencies, public and private corporations and various partners including international organizations, governments and NGOs. Jack Brewer, five-year National Football League (NFL) veteran and former three-team captain, launched BSI in Minneapolis and expanded to New York, Dallas, Miami, Beijing and Malawi. BSI offers a unique financial services platform to professional athletes and sports agencies, as well as high-net-worth individuals and businesses related to professional sports. BSI takes pride in enabling its clients to capitalize on the endless opportunities presented through sport. For more information, please visit www.brewersports.com or follow them on Facebook, Twitter and LinkedIn.
About MDM Worldwide
MDM Worldwide Solutions, Inc. is a digital communications agency that develops and manages online engagement strategies to connect companies with their stakeholders. MDM specializes in working with clients in the technology, healthcare and life sciences spaces. MDM's vast industry knowledge, proprietary methodology, proven track record and experienced leadership team enables them to create and customize targeted digital marketing campaigns to fulfill all of their clients' objectives. For more information, please visitmdmworldwide.com or find them on Facebook, Twitter, Google+ and LinkedIn.
Amarantus Bioscience Holdings, Inc.:
Russell Miller, Director of Investor Relations
408.737.2734 x 101
ir@amarantus.com
Brewer Sports International:
Kristi Hofacker, Director of Interactive Marketing & Media
The Brewer Group, Inc.
kristi.hofacker@thebrewergroup.com
651.247.4460